Innovative Clinical Trials Program - Interdisciplinary Chronic Disease Collaboration
创新临床试验计划——跨学科慢性病合作
基本信息
- 批准号:416066
- 负责人:
- 金额:$ 218.55万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2019
- 资助国家:加拿大
- 起止时间:2019-11-01 至 2023-11-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Chronic diseases are associated with shorter lifespans, frequent contact with the health care system, and reduced quality of life. New ways of delivering health services are needed to promote health and ensure consistent, high quality care for Canadians l
慢性病与寿命缩短、与医疗保健系统频繁接触以及生活质量下降有关。需要提供新的卫生服务方式,以促进健康,确保加拿大人获得一致的高质量护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Matthew T其他文献
James Matthew T的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Matthew T', 18)}}的其他基金
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
用西司他丁 (PONTIAC) 预防肾毒素引起的急性肾损伤试验
- 批准号:
485526 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Operating Grants
Better Prediction and Decision Support Tools to Improve Care and Outcomes for Patients with Acute Kidney Injury (AKI)
更好的预测和决策支持工具可改善急性肾损伤 (AKI) 患者的护理和结果
- 批准号:
312906 - 财政年份:2014
- 资助金额:
$ 218.55万 - 项目类别:
Operating Grants
A Prognostic Tool To Inform Management of Acute Coronary Syndrome in People with Kidney Disease
为肾病患者急性冠脉综合征治疗提供信息的预后工具
- 批准号:
305276 - 财政年份:2014
- 资助金额:
$ 218.55万 - 项目类别:
Operating Grants
Mobilizing Knowledge Across the Continuum of Care for Acute Kidney Injury
在急性肾损伤的连续护理过程中调动知识
- 批准号:
311600 - 财政年份:2013
- 资助金额:
$ 218.55万 - 项目类别:
Salary Programs
Mobilizing Knowledge Across the Continuum of Care for Acute Kidney Injury
在急性肾损伤的连续护理过程中调动知识
- 批准号:
301889 - 财政年份:2013
- 资助金额:
$ 218.55万 - 项目类别:
Salary Programs
Predicting the need for community care for chronic kidney disease following hospitalization with acute kidney injury
预测因急性肾损伤住院后慢性肾病社区护理的需求
- 批准号:
267438 - 财政年份:2012
- 资助金额:
$ 218.55万 - 项目类别:
Operating Grants
Processes of Care and Clinical Outcomes of Acute Kidney Injury: A Multidisciplinary Research Program
急性肾损伤的护理过程和临床结果:多学科研究项目
- 批准号:
264833 - 财政年份:2012
- 资助金额:
$ 218.55万 - 项目类别:
Salary Programs
Coronary angiography and revascularization for patients with Stage 4 and 5 non-dialysis chronic kidney disease: A decision analysis
4 期和 5 期非透析慢性肾病患者的冠状动脉造影和血运重建:决策分析
- 批准号:
205020 - 财政年份:2009
- 资助金额:
$ 218.55万 - 项目类别:
Operating Grants
相似海外基金
Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
- 批准号:
10092585 - 财政年份:2024
- 资助金额:
$ 218.55万 - 项目类别:
Collaborative R&D
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease
血红素介导的线粒体损伤、衰老、急性肾损伤和慢性肾病
- 批准号:
10656648 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
The Role of Patient Capacity in Chronic Kidney Disease Trajectories
患者能力在慢性肾脏病轨迹中的作用
- 批准号:
10737920 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Mitigating the Effects of Structural Racism on Chronic Kidney Disease Disparities among African Americans
减轻结构性种族主义对非裔美国人慢性肾病差异的影响
- 批准号:
10742680 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Anti-Müllerian hormone and cardiovascular risk in males with chronic kidney disease: A protocol.
患有慢性肾病的男性的抗苗勒氏管激素和心血管风险:一个方案。
- 批准号:
481028 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Effects of HIF-PHD inhibitors on copper metabolism and association with organ damage in chronic kidney disease.
HIF-PHD 抑制剂对铜代谢的影响及其与慢性肾脏病器官损伤的关系。
- 批准号:
23K15258 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Iron homeostasis and monocyte differentiation in patients with chronic kidney disease
慢性肾病患者的铁稳态和单核细胞分化
- 批准号:
10648527 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Acute Kidney Injury in Children with Chronic Kidney Disease
慢性肾病儿童的急性肾损伤
- 批准号:
10638267 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别:
Mechanisms of Mitochondrial Metabolic Dysfunction in Chronic Kidney Disease
慢性肾脏病线粒体代谢功能障碍的机制
- 批准号:
10862480 - 财政年份:2023
- 资助金额:
$ 218.55万 - 项目类别: